Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC RBN-3143 | 2360853-16-1 | C22H28FN3O4S | 5 MG
SDP

Catalog No. 5000375692
Encompass_Preferred

RBN-3143 is a potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM. It inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines. It can be used in research of lung inflammation.

  • Potent and NAD+-competitive catalytic PARP14 inhibitor
  • Inhibits PARP14-mediated ADP-ribosylation
  • Stabilizes PARP14 in cell lines
  • Used in research of lung inflammation
  • Improves steroid-resistant asthma mouse models
  • Suppresses alarmins TSLP, IL-33, and IL-25 in mouse models of asthma

Catalog No. 50-003-75692 Supplier Medchemexpress LLC Supplier No. HY1502075MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

RBN-3143 is a potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM. It inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines. It can be used in research of lung inflammation.

  • Potent and NAD+-competitive catalytic PARP14 inhibitor
  • Inhibits PARP14-mediated ADP-ribosylation
  • Stabilizes PARP14 in cell lines
  • Used in research of lung inflammation
  • Improves steroid-resistant asthma mouse models
  • Suppresses alarmins TSLP, IL-33, and IL-25 in mouse models of asthma

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.